PUMA pathway is a weak link in breast cancer metastasis

December 11, 2017, JCI Journals

Substantial advancements have improved the success of chemotherapy, radiation, and surgical treatments for primary breast cancers. However, breast cancer that has spread, or metastasized, to other parts of the body remains a challenge to cure. It is difficult to predict whether a tumor will recur and metastasize, and uncertainty can lead to inadequate or overaggressive treatment.

The cells that initiate metastasis often resemble , a population of that enable development during adulthood. During pregnancy, hormonal signaling activates healthy stem cells, which initiate mammary gland remodeling that supports breast milk production. Now, a new study from Jay Desgrosellier's lab at UCSD has used the activation signature of mammary stem cells to identify vulnerabilities in stem-like metastasis-initiating cells.

In a study published this week in the JCI, Sun et al. report that low-level expression of a protein called PUMA (p53-upregulated modulator of apoptosis) distinguishes stem-like cells in cancer patients who experienced tumor recurrence during a 10-year follow-up period. The cells' ability to suppress PUMA levels was critical to their survival-enhancing PUMA expression selectively depleted stem-like properties and reduced metastasis, whereas reducing PUMA restored metastasis in cultured cells.

Together, these findings expose a possible Achilles heel in aggressive breast cancers that may enable earlier identification and better targeting of metastases. Present limitations in the ability to predict and eliminate aggressive cancer cells likely contribute to the majority of deaths from , but the development of adjuvant approaches that exploit their weaknesses may greatly improve disease outcomes.

Explore further: Researchers identify oestrogen receptor stem cells in the mammary gland.

More information: Qi Sun et al, Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI93707

Related Stories

Researchers identify oestrogen receptor stem cells in the mammary gland.

August 16, 2017
One of the key questions in stem cell and cancer biology is to understand the cellular hierarchy governing tissue development and maintenance and the cancer cell of origin. In a study published in Cell Reports, researchers ...

Fighting cancer: Natural and synthetic progestin therapies in post-menopausal women help breast cancer grow and spread

July 12, 2017
Hormone replacement therapies, or medications containing female hormones that substitute those no longer produced by the body, often are prescribed to reduce the effects of menopausal symptoms in women. Research has indicated ...

MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients

February 5, 2013
Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the American ...

How breast cancer usurps the powers of mammary stem cells

August 11, 2014
During pregnancy, certain hormones trigger specialized mammary stem cells to create milk-producing cells essential to lactation. Scientists at the University of California, San Diego School of Medicine and Moores Cancer Center ...

ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression

August 2, 2017
ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression, according to a study published August 2, 2017 in the open-access journal PLOS ONE by Varun Vijay Prabhu from Oncoceutics, Inc., USA and ...

Study identifies RNA molecule that shields breast cancer stem cells from immune system

May 22, 2017
Researchers from Princeton University's Department of Molecular Biology have identified a small RNA molecule that helps maintain the activity of stem cells in both healthy and cancerous breast tissue. The study, which will ...

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.